Small Molecule 5-HT6R Ligands: A Comprehensive Insight into their Selectivity and Activity
Alexandre V. Ivachtchenko,
Yan A. Ivanenkov.
In recent years, considerable research efforts have focused on the role of serotonin in various pathological
states, as well as on the identification of the respective serotonin receptors involved. Among serotonin receptors, 5-HT6R
is the most recently discovered sub-class. Despite the development of multiple selective ligands, the functional role of this
receptor has thus far remained elusive. Available in vitro and in vivo evidence indicates that 5-HT6 receptor antagonists
can produce promnesic or antiamnesic effects in a variety of contexts, including memory formation, age-related cognitive
impairments, and memory deficits associated with conditions such as schizophrenia, Parkinson’s disease, and Alzheimer's
disease. Recent progress in the understanding of the 5-HT6 receptor and its ligands includes a suggested constitutive activity
for the receptor, development of a number of multimodal small molecule ligands, and re-classification of many selective
antagonists as pseudo-selective compounds. In light of these findings, the observed pharmacological effects produced
by 5-HT6R ligands are now properly assigned to a spectrum of related biological targets, rather than to an individual receptor.
Keywords: Serotonin receptors, 5-HT6R ligands, selectivity, depression, schizophrenia, Alzheimer’s disease, Huntington's disease,
Rights & PermissionsPrintExport